Allocating health care resources when people are risk averse with respect to life time

Health Economics

Volumn 12, Issue 7, 2003, Pages 601-608

  Hoel, Michael ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cost effectiveness analysis; Health management; HYE; QALY; Risk aversion

Indexed keywords

ARTICLE; BUDGET; COST EFFECTIVENESS ANALYSIS; HEALTH CARE MANAGEMENT; HEALTH ECONOMICS; LIFESPAN; PRIORITY JOURNAL; QUALITY OF LIFE; RESOURCE ALLOCATION; RISK BENEFIT ANALYSIS; SOCIAL WELFARE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; HEALTH CARE RATIONING; HUMANS; MEDICAL FUTILITY; QUALITY-ADJUSTED LIFE YEARS; RESOURCE ALLOCATION; RISK ASSESSMENT; SOCIAL WELFARE; UNCERTAINTY;

EID: 0038726248     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.733     Document Type: Article

References (21)

1. Harris J. QALYfying the value of life. J Med Ethics 1987; 13: 117-123.
2. Wagstaff A. QALYs and the equity-efficiency trade-off. J Health Econ 1991; 10: 21-41.
3. Nord E. The QALY - a measure of social value rather than individual utility? Health Econ 1994; 3: 89-93.
4. Olsen JA. Theories of justice and their implications for priority setting in health care. J Health Econ 1997; 16: 625-639.
5. Dolan P. The measurement of individual utility and social welfare. J Health Econ 1998; 17: 39-52.
6. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health analysis and medical practices. N Engl J Med 1977; 296: 716-721.
7. Pliskin JS, Shepard DS, Weinstein MC. Utility functions for life years and health status. Operations Res 1980; 28: 206-224.
8. Mehrez A, Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decision Making 1989; 9: 142-149.
9. Broome J. Qalys. J Public Econ 1993; 50: 149-167.
10. Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. J Health Econ 1993; 12: 459-467.
11. Gabler AM, Phelps CE. Economic foundation of cost-effectiveness analysis. J Health Econ 1997; 16: 1-31.
12. Bleichrodt H, Quiggin J. Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?' J Health Econ 1999; 18: 681-708.
13. Nord E. Cost-Value Analysis in Health Care: Making Sense Out of QALYs. Cambridge University Press: Cambridge, 1999.
14. Bleichrodt H. QALYs and HYEs. Under what circumstances are they equivalent? J Health Econ 1995; 14: 17-37.
15. Stiggelbout A, Kiebert G, Kievit J, et al. Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gambles. Med Decision Making 1994; 14: 82-90.
16. Johannesson M, Johansson P. To be, or not to be, that is the question: an empirical study of the WTP for an increased life expectancy at an advanced age. J Risk Uncertainty 1996; 13: 163-174.
17. Zivin JG. Cost-effectiveness analysis with risk aversion. Health Econ 2001; 10: 499-508.
18. Pratt JW, Zeckhauser RJ. Willingness to pay and the distribution of risk and wealth. J Political Economy 1996; 104: 747-763.
19. Bleichrodt H, Wakker P, Johannesson M. Characterizing QALYs by risk neutrality. J Risk Uncertainty 1997; 15: 151-165.
20. Culyer AJ, Wagstaff A. QALYs versus HYEs. J Health Econ 1993; 12: 311-323.
21. Gafni A, Birch S, Mehrez A. Economics, health and health economics: HYEs versus QALYs. J Health Econ 1993; 12: 325-339.